Hengrui Medicine (01276.HK) invested approximately 5.6245 million yuan to repurchase 120,000 A-shares on June 17th.

The Zhitong Finance and Economics APP news: Hengrui Medicine (01276.HK) announced that on June 17, 2026, the company will spend approximately RMB 5.6245 million to repurchase 120,000 A-shares, with a repurchase price of RMB 46.85 to 46.88 per share.